Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Hier à 19:48

Novartis inks $2.1B Endocyte buyout, furthering radiotherapy push

Il y a 2 jours
Novartis has struck a $2.1 billion (€1.8 billion) deal to acquire Endocyte. The deal caps off a whirlwind year for Endocyte, which licensed the cancer drug that caught Novartis’ eye for $12 million...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57

Patenting Therapies in the Microbiome Field

Il y a 3 jours
In recent years, our understanding of the human microbiome has reached an exciting momentum. It is no longer seen as a bunch of foreign invaders of the body, but rather more as a pseudo-organ that...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Hier à 15:43

Amgen buys $66M stake in pocket-sized DNA sequencer maker Oxford Nanopore

Il y a 2 jours
Amgen has invested $66 million (£50 million) into portable genome sequencer developer Oxford Nanopore. The Big Pharma hopes the investment will align with its efforts in using genomics to inform its...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 14:05

Gilead, Aelix ally to trial HIV-suppressing combination

Il y a 2 jours
Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take antiretroviral drugs. The planned clinical trial will test Gilead’s TLR7...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12

Liver Gene Therapy 8 Times Stronger Than Usual

Il y a 2 jours
Synpromics and UniQure have unveiled new technology for precise genetic control that could make gene therapy safer and more precise. The team has developed a gene therapy system that is highly...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Hier à 11:52

Ziopharm’s R&D head joins Spectrum as CMO

Il y a 2 jours
Ziopharm Oncology’s executive vice president of R&D, Francois Lebel, M.D., is moving to cancer drugmaker Spectrum Pharmaceuticals to serve as its chief medical officer effective Nov. 5....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34

Phase III Triumph for Topical Hormonal Acne Treatment

Il y a 2 jours
The Italian biotech Cassiopea reports good news for acne sufferers. Its hormonal anti-acne treatment Winlevi significantly helped to reduce acne in two Phase III trials. Winlevi, when applied to the...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Hier à 07:36

After putting £35M into MiNA Therapeutics, Sosei passes on buyout option

Il y a 2 jours
In May 2017, Sosei invested £35 million in MiNA Therapeutics with an option to buy the RNA biotech out. Now, the Tokyo-based company is passing on that option, giving up the right to acquire MiNA in...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Roche sheds clutch of in-licensed drugs in pipeline cull

Il y a 3 jours
The most advanced drug to get the chop is RG6125, an anti-cadherin 11 antibody that entered a phase 2 rheumatoid arthritis trial last year....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Bite Down On These New Biotech Jobs

Il y a 3 jours
Hello biotechnologists, Time to leap into a new biotech job! Check out the position of Senior Scientist at Selvita or become the Marketing Manager at Bluebird Bio. Just starting out? Check out the...
labiotech.eu
Charger plus d'actualités